FIELD: medicine.
SUBSTANCE: method involves the examination of the patient with detecting pathological situations and specifying forming spastic and paretic antagonist muscles. In addition, electrical conductance of the BAP of C, F, RP, V meridians is measured by Nakatani method. The hyperfunctioning C meridian observed indicates the residual perinatal cortical hypoxias. The hyperfunctioning F meridian shows dysfunction of brain stem structures. The hypo- or hyperfunctioning RP meridian is an evidence of cerebrospinal fluid circulation disturbance. The hypo- or hyperfunctioning V meridian enables to observe decreased liquor absorption. A central pathogenesis link is involved by exposing on such BAPs of classical meridians as lo-points, associate points, tonic points and joint points. Such scalp regions as an initiative zone, an active thinking zone or a motional consequence zone are covered additionally. The BAPs exposure both on the central pathogenesis link, and on the peripheral neuromuscular apparatus is enabled by direct negative polarity current in a sedative exposure mode, and/or by direct alternated polarity current pulses in a toning exposure mode. The peripheral neuromuscular apparatus is covered by sedative exposure on spastic muscle and toning exposure - on paretic muscles, and also by sedative exposure on paravertebral BAPs considering the segmental innervation of spastic muscles.
EFFECT: method improves clinical effectiveness in ICP ensured by maintained combination of reflex and direct exposure on muscular fibres of spastic and paretic antagonist muscles, decreased stretch reflex and relief of pathological situations, clinical efficiency in ICP for the patients with the evident manifestations of hydrocephaly and organic cerebral damage caused by medical exposure on individual combinations of pathogenesis elements.
7 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING MENTAL AND SPEECH DEVELOPMENT DELAY IN NEUROLOGIC-AND-BEHAVIORAL DEVELOPMENT DISEASES CASES | 2005 |
|
RU2305537C2 |
METHOD FOR TREATING THE CASES OF HYPERTENSIVE-HYDROCEPHALIC SYNDROME AND ITS CONSEQUENCES | 2005 |
|
RU2317062C2 |
METHOD OF TREATING AUTISM SPECTRUM DISORDERS | 2019 |
|
RU2716754C2 |
METHOD OF TREATMENT OF DELAYED PSYCHO-SPEECH AND MOTOR DEVELOPMENT IN CHILDREN WITH NEURO-MENTAL DISEASES | 2021 |
|
RU2801025C2 |
METHOD FOR TREATMENT OF DELAY OF PSYCHOREAL DEVELOPMENT AND MOTOR DISORDERS IN NERVOUS-MENTAL DISEASES OF PATIENTS | 2016 |
|
RU2646571C2 |
METHOD OF TREATING AUTOIMMUNE DISEASES OF THYROID GLAND | 2010 |
|
RU2434628C2 |
METHOD OF TREATING MOTOR-VEGETATIVE DISTURBANCES | 2009 |
|
RU2410076C1 |
METHOD FOR TREATMENT OF SPASTICITY WITH MUSCLE FIBROSIS IN CHILDREN | 2020 |
|
RU2755762C1 |
METHOD FOR COMPLEX REHABILITATION OF UPPER EXTREMITY MOTOR FUNCTION IN PATIENTS WITH INFANTILE CEREBRAL PARALYSIS | 2020 |
|
RU2741221C1 |
METHOD OF COMPLEX REHABILITATION OF MOTOR FUNCTION OF UPPER LIMB IN PATIENTS WITH CEREBRAL PALSY | 2023 |
|
RU2810440C1 |
Authors
Dates
2010-10-10—Published
2009-08-13—Filed